“…Etomidate has long been the drug of choice for intubating the hemodynamically unstable patient due to rapid onset, cardioprotective nature, and hemodynamic 12 randomized clinical trials with various levels of blinding and controls. Two systematic reviews of etomidate's mortality influence (Level I evidence) were also found [2,3]. Articles were included in this review if they were a systematic review or met the following inclusion criteria: induction of anesthesia studied, being performed in a hospital setting, a control group was clearly identifiable, statistical analysis was sufficiently performed including p values, and all results were clearly stated and discussed.…”